• Aust Prescr · Oct 2020

    Review

    Harms and benefits of sodium-glucose co-transporter 2 inhibitors.

    • Thomas Chesterman and Tilenka Rj Thynne.
    • Southern Adelaide Diabetes and Endocrine Service, South Australia Health.
    • Aust Prescr. 2020 Oct 1; 43 (5): 168-171.

    Sodium Glucose Co Transporter 2 Inhibitors Are Oral Glucose Lowering Drugs That Increase The Urinary Excretion Of Glucose In Patients With Type 2 Diabetes And Cardiovascular Disease They Reduce All Cause Mortality Cardiac Mortality Rates Of Hospitalisation For Heart Failure And The Progression Of Renal DiseaseThere Are Adverse Effects Related To The Mechanism Of Action These Include Polyuria And Intravascular Volume Depletion From Osmotic Diuresis And Genitourinary Infections From Glycosuria Ketoacidosis Is A Rare Adverse EffectThe Glucose Lowering Efficacy Of Sodium Glucose Co Transporter 2 Inhibitors Decreases With Increasing Renal Impairment(c) NPS MedicineWise.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…